ACLX - Arcellx Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.523B

Cash

533.6M

Avg Qtr Burn

N/A

Short % of Float

14.30%

Insider Ownership

15.44%

Institutional Own.

92.36%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
CART-ddBCMA (iMMagine-1) Details Multiple myeloma	Phase 2 Interim update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ACLX-001 (ARC-SparX program) Details Multiple myeloma	Phase 1 Interim update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.